TdT Antikörper (AA 1-509) (HRP)
Kurzübersicht für TdT Antikörper (AA 1-509) (HRP) (ABIN7150216)
Target
Alle TdT (DNTT) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-509
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human DNA nucleotidylexotransferase protein (1-509AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- TdT (DNTT) (Deoxynucleotidyltransferase, terminal (DNTT))
-
Andere Bezeichnung
- DNTT
-
Hintergrund
-
Background: Template-independent DNA polymerase which catalyzes the random addition of deoxynucleoside 5\'-triphosphate to the 3\'-end of a DNA initiator. One of the in vivo functions of this enzyme is the addition of nucleotides at the junction (N region) of rearranged Ig heavy chain and T-cell receptor gene segments during the maturation of B- and T-cells.
Aliases: Deoxynucleotidyltransferase terminal antibody, DNA nucleotidylexotransferase antibody, DNTT antibody, Nucleosidetriphosphate DNA deoxynucleotidylexotransferase antibody, TDT antibody, TDT_HUMAN antibody, Terminal addition enzyme antibody, Terminal deoxynucleotidyltransferase antibody, Terminal deoxyribonucleotidyltransferase antibody, Terminal transferase antibody
-
UniProt
- P04053
-
Pathways
- DNA Reparatur
Target
-